July 15, 2026 · Form 4 insider transaction
Kalb Michael Wayne sold 131,536 shares of Catalyst Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option.; Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger.